Vytorin on Carotid Intima-media Thickness and Overall Rigidity.
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2011
At a glance
- Drugs Ezetimibe; Ezetimibe/simvastatin; Pravastatin; Simvastatin
- Indications Atherosclerosis
- Focus Pharmacodynamics
- Acronyms VYCTOR
- 05 Oct 2011 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
- 05 Oct 2011 Company (Merck) added as trial sponsor as reported by ClinicalTrials.gov.
- 05 Oct 2011 Additional lead trial centre (Hospital Universitario 12 de Octubre) and investigator (Alejandra Meaney) identified as reported by ClinicalTrials.gov.